Showing results (71-80 of 5,640) with videos related to
Sort By:
Pageof 564
Neuroendocrinology|March 21, 2021
Early Pulse Glucocorticoid Therapy and Improved Hormonal Outcomes in Primary HypophysitisBrijesh Krishnappa, Ravikumar Shah, Vijaya Sarathi, et al.Neuroendocrinology|April 1, 1988
Central serotoninergic stimulation by fenfluramine challenge does not affect plasma thyrotropin-stimulating hormone levels in manE F Coccaro, L J Siever, I A Kourides, et al.Neuroendocrinology|April 1, 1988
The neurohormonal thymic microenvironment: immunocytochemical evidence that thymic nurse cells are neuroendocrine cellsV Geenen, M P Defresne, F Robert, et al.Neuroendocrinology|December 28, 2021
GABAB Receptor Antagonism from Birth to Weaning Permanently Modifies Kiss1 Expression in the Hypothalamus and Gonads in MiceMarianne Bizzozzero-Hiriart, Noelia P Di Giorgio, Carlos Libertun, et al.Neuroendocrinology|December 28, 2021
Associations between Prolactin, Diabetes, and Cognitive Impairment: A Literature ReviewHai Duc Nguyen, Hojin Oh, Byung Pal Yu, et al.Neuroendocrinology|September 14, 2011
Identification of CD133+ cells in pituitary adenomasShunji Yunoue, Kazunori Arita, Hiroto Kawano, et al.Neuroendocrinology|February 14, 2012
Involvement of α2-adrenoceptor subtypes A and C in glucose homeostasis and adrenaline-induced hyperglycaemiaSuvi T Ruohonen, Saku Ruohonen, Ralf Gilsbach, et al.Neuroendocrinology|February 14, 2012
MC4R dimerization in the paraventricular nucleus and GHSR/MC3R heterodimerization in the arcuate nucleus: is there relevance for body weight regulation?Anne Rediger, Carolin Leonie Piechowski, Kirk Habegger, et al.Neuroendocrinology|February 21, 2012
Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and NotchYvette Carter, Renata Jaskula-Sztul, Herbert Chen, et al.Neuroendocrinology|January 18, 2012
Diffuse endocrine system, neuroendocrine tumors and immunity: what's new?Pietro Ameri, Diego FeronePageof 564